Harvard Bioscience Overview

Harvard Bioscience Cost of Revenue

Cost of Revenue analysis for HBIO.

Quarterly Cost of Revenue

$8.51M

↓ 11.25% YoY

As of Mar 31, 2026

Annual Cost of Revenue (TTM)

$39.59M

↓ 2.37% YoY

Trailing 12 months ending Mar 31, 2026

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin